Organon & Co.
OGN
$7.21
$0.040.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.30B | 6.28B | 6.29B | 6.40B | 6.41B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.30B | 6.28B | 6.29B | 6.40B | 6.41B |
| Cost of Revenue | 2.80B | 2.73B | 2.69B | 2.69B | 2.68B |
| Gross Profit | 3.50B | 3.55B | 3.61B | 3.72B | 3.73B |
| SG&A Expenses | 1.76B | 1.77B | 1.75B | 1.76B | 1.68B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.97B | 4.93B | 4.89B | 4.92B | 4.83B |
| Operating Income | 1.33B | 1.35B | 1.40B | 1.48B | 1.58B |
| Income Before Tax | 702.00M | 666.00M | 672.00M | 807.00M | 782.00M |
| Income Tax Expenses | 201.00M | -34.00M | -78.00M | -57.00M | -519.00M |
| Earnings from Continuing Operations | 501.00 | 700.00 | 750.00 | 864.00 | 1.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 501.00M | 700.00M | 750.00M | 864.00M | 1.30B |
| EBIT | 1.33B | 1.35B | 1.40B | 1.48B | 1.58B |
| EBITDA | 1.68B | 1.67B | 1.70B | 1.76B | 1.84B |
| EPS Basic | 1.93 | 2.71 | 2.91 | 3.36 | 5.07 |
| Normalized Basic EPS | 1.95 | 1.96 | 2.10 | 2.25 | 2.49 |
| EPS Diluted | 1.91 | 2.68 | 2.87 | 3.32 | 5.04 |
| Normalized Diluted EPS | 1.94 | 1.95 | 2.08 | 2.23 | 2.48 |
| Average Basic Shares Outstanding | 1.04B | 1.03B | 1.03B | 1.03B | 1.03B |
| Average Diluted Shares Outstanding | 1.04B | 1.04B | 1.04B | 1.04B | 1.03B |
| Dividend Per Share | 0.60 | 0.86 | 1.12 | 1.12 | 1.12 |
| Payout Ratio | 31.54% | 32.71% | 39.73% | 34.38% | 22.75% |